Skip to main content
KUKJEON PHARMACEUTICAL Co.,Ltd logo

KUKJEON PHARMACEUTICAL Co.,Ltd — Investor Relations & Filings

Ticker · 307750 ISIN · KR7307750000 KO Manufacturing
Open in API
Filings indexed 320 across all filing types
Latest filing 2026-03-09 Proxy Solicitation & In…
Country KR South Korea
Listing KO 307750

About KUKJEON PHARMACEUTICAL Co.,Ltd

https://www.kukjeon.co.kr/en/

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company's portfolio includes raw materials for specialized medicines such as choline alfoscerates, benfothiamines, and napamostat. A key product is Itopride hydrochloride, a functional indigestion treatment, for which the company holds a proprietary manufacturing patent. In addition to its pharmaceutical focus, the company also develops and supplies chemical materials for the electronics industry.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Kukje Pharma. It outlines the date, location, and specific agenda items for the upcoming Annual General Meeting (AGM), including the approval of financial statements, changes to the articles of incorporation, and the appointment of directors. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2026-03-09 Korean
신주인수권행사
Share Issue/Capital Change Classification · 1% confidence The document is a formal notification regarding the exercise of stock warrants (신주인수권행사) by Kukje Pharma. It details the number of shares exercised, the impact on total issued shares, and the schedule for listing. This falls under the category of capital changes resulting from the exercise of financial instruments, which is classified as 'Share Issue/Capital Change' (SHA).
2026-03-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and collateral agreements (stock-backed loans) of major shareholders and their special relations. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 1% confidence The document is a regulatory filing from a Korean company (Kukje Pharma) disclosing a significant change in financial results (revenue or profit/loss structure exceeding 15% for large corporations or 30% for others). This is a standard mandatory disclosure in the Korean market (DART system) regarding preliminary financial results before the final audit report is finalized. Since it provides the initial highlights of the financial performance for the fiscal year, it falls under the 'Earnings Release' category.
2026-02-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document specifically details changes in share ownership, including major shareholding notifications and changes in collateral agreements (stock-backed loans) by the company's largest shareholder. This falls under the 'Major Shareholding Notification' category.
2026-02-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and contractual obligations (such as stock-backed loans) of major shareholders and their special relations. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-01-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.